Kathmandu, March 16. On Tuesday, the American Biopharmaceutical company, Moderna announced that it has begun the vaccine trials of its mRNA-1273 vaccine for children aged 6 months to 12 years.  According to the official statement, 6,750 healthy children from the United States and Canada will participate as volunteers in the second phase study of the … Continue reading Moderna announces Vaccine Trials For Children